Forecast

The analysts' average price target is €15.76 (-28.00%). The median is €15.48 (-29.28%).

Buy	2
Hold	7
Sell	2

News Go to news feed

ProAssurance reaches 52-week high and makes progress on acquisition by The Doctors Company

Shares of ProAssurance Corp. hit a new 52-week high at $23.96, marking an increase of over 100% in the past year. The planned acquisition by The Doctors Company is moving forward after the US antitrust authority ended the waiting period early and shareholders approved the transaction by a large majority. The acquisition is expected to close in the first half of 2026, pending further regulatory approvals. » More on de.investing.com
ProAssurance reaches 52-week high as shareholders approve acquisition by The Doctors Company

ProAssurance shares hit a new 52-week high at $23.95, showing strong performance over the past year. Shareholders overwhelmingly approved the planned acquisition by The Doctors Company, with over 99% voting in favor. The deal is expected to close in the first half of 2026, pending regulatory approvals. After the acquisition, ProAssurance will become a wholly owned subsidiary of The Doctors Company and will be delisted from the New York Stock Exchange. » More on de.investing.com
ProAssurance hits 52-week high ahead of acquisition by The Doctors Company

Shares of ProAssurance reached a new 52-week high after shareholders overwhelmingly approved the planned acquisition by The Doctors Company. The deal is expected to close in the first half of 2026, pending further regulatory approvals, after which ProAssurance will be delisted. However, analysts have raised concerns about the valuation and the company's future earnings potential. » More on de.investing.com

Historical dividends Dividends

All dividend metrics All metrics

In 2023, Proassurance Co. has already paid €0.0918 in dividends. The last payout was in April 2023.

Financials

In the last quarter, Proassurance Co. had revenue of €226.89M and net profit of €7.31M

(EUR)	March 2026	YoY
Revenue	226.89M	8.43%
Gross profit	76.4M	80.78%
Net profit	7.31M	235.82%
EBITDA	14.85M	506.43%

Fundamentals

Metric	Value
Market capitalization	€1.11B
Number of shares	51.61M
52-week high/low	€21.52 - €19.61
Dividends	No
Beta	0.04
P/E ratio	19.71
PEG ratio	0.37
P/B ratio	0.96
P/S ratio	1.20

Company profile

Die ProAssurance Corporation bietet über ihre Tochtergesellschaften Sach- und Unfallversicherungen sowie Rückversicherungsprodukte in den Vereinigten Staaten an. Das Unternehmen ist in den Segmenten Specialty Property and Casualty, Workers' Compensation Insurance, Segregated Portfolio Cell Reinsurance und Lloyd's Syndicate tätig. Das Unternehmen bietet Berufshaftpflichtversicherungen für Gesundheitsdienstleister und -einrichtungen sowie Rechtsanwälte, Haftpflichtversicherungen für medizintechnische und biowissenschaftliche Risiken und Arbeiterunfallversicherungen, wie z. B. Policen mit Kostengarantie, Policen mit Versicherungsnehmerdividende, rückwirkend bewertete Policen und Policen mit Selbstbeteiligung, sowie alternative Marktlösungen, die Programmgestaltung, Fronting, Schadensverwaltung, Risikomanagement, SPC-Vermietung, Vermögensverwaltung und SPC-Managementdienste für einzelne Unternehmen, Agenturen, Gruppen und Verbände umfassen. Das Unternehmen ist auch am Syndikat 1729 von Lloyd's of London beteiligt, das Sach- und Unfallversicherungen sowie Rückversicherungen zeichnet. Es vertreibt seine Produkte über unabhängige Agenturen und Makler sowie über einen eigenen Außendienst. Das Unternehmen wurde 1976 gegründet und hat seinen Hauptsitz in Birmingham, Alabama.

Name	Proassurance Co.
CEO	Edward Lewis Rand Jr.
Headquarters	Birmingham, al USA
Website	proassurance.com
Sector	Financials
Industry	Insurance
IPO	09/04/1991
Employees	972